ATE452642T1 - Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen - Google Patents
Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungenInfo
- Publication number
- ATE452642T1 ATE452642T1 AT05024864T AT05024864T ATE452642T1 AT E452642 T1 ATE452642 T1 AT E452642T1 AT 05024864 T AT05024864 T AT 05024864T AT 05024864 T AT05024864 T AT 05024864T AT E452642 T1 ATE452642 T1 AT E452642T1
- Authority
- AT
- Austria
- Prior art keywords
- cox
- inhibitors
- affective disorders
- treat affective
- treat
- Prior art date
Links
- 208000019022 Mood disease Diseases 0.000 title 1
- 229940111134 coxibs Drugs 0.000 title 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10129320A DE10129320A1 (de) | 2001-06-19 | 2001-06-19 | Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen |
| US36490402P | 2002-03-14 | 2002-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE452642T1 true ATE452642T1 (de) | 2010-01-15 |
Family
ID=26009543
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05024864T ATE452642T1 (de) | 2001-06-19 | 2002-05-31 | Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen |
| AT02738138T ATE338557T1 (de) | 2001-06-19 | 2002-05-31 | Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02738138T ATE338557T1 (de) | 2001-06-19 | 2002-05-31 | Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20040204469A1 (de) |
| EP (2) | EP1397145B1 (de) |
| JP (2) | JP4205577B2 (de) |
| AP (1) | AP1512A (de) |
| AT (2) | ATE452642T1 (de) |
| AU (1) | AU2002312967A1 (de) |
| CA (1) | CA2448025C (de) |
| CY (1) | CY1109949T1 (de) |
| DE (2) | DE60234873D1 (de) |
| DK (2) | DK1627639T3 (de) |
| EA (1) | EA009780B1 (de) |
| ES (2) | ES2336682T3 (de) |
| OA (1) | OA12627A (de) |
| PT (2) | PT1397145E (de) |
| SI (1) | SI1627639T1 (de) |
| WO (1) | WO2002102297A2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR032641A1 (es) * | 2001-01-29 | 2003-11-19 | Otsuka Pharma Co Ltd | Agonista de subtipo de receptor 5-ht 1a. |
| US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| CN101371843B (zh) * | 2002-11-26 | 2012-09-26 | 艾利斯达医药品公司 | 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用 |
| US20040204411A1 (en) * | 2002-12-17 | 2004-10-14 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
| US20050037983A1 (en) * | 2003-03-11 | 2005-02-17 | Timothy Dinan | Compositions and methods for the treatment of depression and other affective disorders |
| JP2007502856A (ja) * | 2003-05-16 | 2007-02-15 | ファイザー・プロダクツ・インク | 精神病性障害および抑うつ性障害の治療 |
| ATE510174T1 (de) | 2003-05-21 | 2011-06-15 | Alexza Pharmaceuticals Inc | Schlag gezündete unabhängige heizeinheit |
| CA2536161A1 (en) * | 2003-08-27 | 2005-03-10 | Eli Lilly And Company | Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors |
| WO2005048999A2 (en) * | 2003-11-19 | 2005-06-02 | Glaxo Group Limited | Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders |
| WO2005049034A2 (en) * | 2003-11-19 | 2005-06-02 | Glaxo Group Limited | Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders |
| US20050171088A1 (en) * | 2004-01-30 | 2005-08-04 | Astrazeneca Ab | Treatment of psychoses with dibenzothiazepine antipsychotic |
| CA2556380A1 (en) * | 2004-03-02 | 2005-09-15 | Pharmacia Corporation | Methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| AU2004322756B2 (en) | 2004-08-12 | 2011-04-14 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| US20070281927A1 (en) * | 2006-06-06 | 2007-12-06 | Shanthakumar Tyavanagimatt | Anti-inflammatory and analgesic compositions and related methods |
| GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
| US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| JP5144104B2 (ja) | 2007-04-09 | 2013-02-13 | ユニ・チャーム株式会社 | 伸縮性複合シート及びそれを用いた使い捨て着用物品 |
| EP2485744A4 (de) * | 2009-10-09 | 2014-01-22 | Prothera Inc | Zusammensetzungen und verfahren mit pediokokken zur reduzierung mindestens eines symptoms für autismusspektrumserkrankungen bei einem patienten mit diagnostizierter autismusspektrumserkrankung |
| EP2340818A1 (de) * | 2009-12-23 | 2011-07-06 | Laboratorios Del. Dr. Esteve, S.A. | Kokristalle von Venlafaxin und Celecoxib |
| EP2340819A1 (de) * | 2009-12-23 | 2011-07-06 | Laboratorios Del. Dr. Esteve, S.A. | Zusammensetzungen mit Venlafaxin und Celecoxib zur Behandlung von Schmerzen |
| US10369134B2 (en) | 2017-12-05 | 2019-08-06 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| MX2020005517A (es) | 2017-12-05 | 2020-11-09 | Sunovion Pharmaceuticals Inc | Formas cristalinas y metodos de produccion de las mismas. |
| US12214118B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
| WO2020247627A1 (en) | 2019-06-04 | 2020-12-10 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579846A (en) * | 1984-10-11 | 1986-04-01 | Pfizer Inc. | Antiinflammatory compositions and methods |
| AU1041599A (en) * | 1997-11-13 | 1999-06-07 | Jose Luis Castro Pineiro | Therapeutic uses of triazolo-pyridazine derivatives |
| DE60035232T2 (de) * | 1999-07-01 | 2008-02-14 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom |
| EP1142889A1 (de) * | 2000-04-03 | 2001-10-10 | Pfizer Products Inc. | Pyrazolderivate als entzündungs-/schmerzhemmende Mittel |
| US6306842B1 (en) * | 2000-06-02 | 2001-10-23 | Medinox, Inc. | Protected forms of a combination of pharmacologically active agents and uses therefor |
-
2002
- 2002-05-31 EA EA200301291A patent/EA009780B1/ru not_active IP Right Cessation
- 2002-05-31 JP JP2003504886A patent/JP4205577B2/ja not_active Expired - Fee Related
- 2002-05-31 DK DK05024864.0T patent/DK1627639T3/da active
- 2002-05-31 SI SI200230890T patent/SI1627639T1/sl unknown
- 2002-05-31 WO PCT/EP2002/006013 patent/WO2002102297A2/en not_active Ceased
- 2002-05-31 AT AT05024864T patent/ATE452642T1/de active
- 2002-05-31 EP EP02738138A patent/EP1397145B1/de not_active Expired - Lifetime
- 2002-05-31 PT PT02738138T patent/PT1397145E/pt unknown
- 2002-05-31 PT PT05024864T patent/PT1627639E/pt unknown
- 2002-05-31 EP EP05024864A patent/EP1627639B1/de not_active Expired - Lifetime
- 2002-05-31 DK DK02738138T patent/DK1397145T3/da active
- 2002-05-31 DE DE60234873T patent/DE60234873D1/de not_active Expired - Lifetime
- 2002-05-31 AT AT02738138T patent/ATE338557T1/de active
- 2002-05-31 AP APAP/P/2003/002934A patent/AP1512A/en active
- 2002-05-31 ES ES05024864T patent/ES2336682T3/es not_active Expired - Lifetime
- 2002-05-31 ES ES02738138T patent/ES2271269T3/es not_active Expired - Lifetime
- 2002-05-31 AU AU2002312967A patent/AU2002312967A1/en not_active Abandoned
- 2002-05-31 OA OA1200300328A patent/OA12627A/en unknown
- 2002-05-31 US US10/480,600 patent/US20040204469A1/en not_active Abandoned
- 2002-05-31 CA CA2448025A patent/CA2448025C/en not_active Expired - Fee Related
- 2002-05-31 DE DE60214542T patent/DE60214542T2/de not_active Expired - Lifetime
-
2008
- 2008-07-22 JP JP2008188890A patent/JP4824727B2/ja not_active Expired - Fee Related
-
2010
- 2010-03-22 CY CY20101100270T patent/CY1109949T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4205577B2 (ja) | 2009-01-07 |
| ES2271269T3 (es) | 2007-04-16 |
| JP4824727B2 (ja) | 2011-11-30 |
| DK1397145T3 (da) | 2007-01-02 |
| AP1512A (en) | 2005-12-15 |
| EP1397145B1 (de) | 2006-09-06 |
| EP1627639B1 (de) | 2009-12-23 |
| EP1397145A2 (de) | 2004-03-17 |
| PT1627639E (pt) | 2010-03-01 |
| EP1627639A3 (de) | 2006-09-27 |
| AP2003002934A0 (en) | 2003-12-31 |
| DE60234873D1 (de) | 2010-02-04 |
| AU2002312967A1 (en) | 2003-01-02 |
| WO2002102297A2 (en) | 2002-12-27 |
| US20040204469A1 (en) | 2004-10-14 |
| WO2002102297A3 (en) | 2003-05-01 |
| DE60214542T2 (de) | 2006-12-21 |
| CY1109949T1 (el) | 2014-09-10 |
| EA009780B1 (ru) | 2008-04-28 |
| CA2448025A1 (en) | 2002-12-27 |
| SI1627639T1 (sl) | 2010-04-30 |
| CA2448025C (en) | 2011-07-05 |
| PT1397145E (pt) | 2006-10-31 |
| OA12627A (en) | 2006-06-13 |
| EA200301291A1 (ru) | 2004-06-24 |
| JP2008297308A (ja) | 2008-12-11 |
| ATE338557T1 (de) | 2006-09-15 |
| DE60214542D1 (de) | 2006-10-19 |
| JP2004534066A (ja) | 2004-11-11 |
| DK1627639T3 (da) | 2010-04-26 |
| EP1627639A2 (de) | 2006-02-22 |
| ES2336682T3 (es) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60234873D1 (de) | Verwendung von COX-2 Inhibitoren zur Behandlung von affectiven Störungen | |
| ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| ATE288748T1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| ATE419856T1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| ATE414556T1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
| ATE308364T1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| DE602004010407D1 (de) | Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden | |
| ATE357440T1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| ATE526982T1 (de) | Verwendung von neublastin-polypeptide zur behandlung von neuropathischen schmerzen | |
| ATE353218T1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
| ATE395075T1 (de) | Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose | |
| ATE509621T1 (de) | Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
| ATE380558T1 (de) | Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| ATE317261T1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| ATE404203T1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| ATE376416T1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen | |
| DE60229047D1 (de) | Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit | |
| ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
| DE10193322D2 (de) | Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates | |
| DE602004003251D1 (de) | Verwendung von indazol-derivaten zur behandlung von neuropathischen schmerzen | |
| EP1646385A4 (de) | Verwendung von benzothiopenen zur behandlung und prävention von prostatakrebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1627639 Country of ref document: EP |